Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 9Phase 1/2 8Phase NA 2Phase 4 1Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Melanoma 2Leukemia, Myeloid, Acute 2Leukemia 2Skin Neoplasms 1Recurrence 1

Interventions

Cytarabine 19Cyclophosphamide 18venetoclax 15fludarabine phosphate 14Busulfan 14Cyclosporine 12Azacitidine 11fludarabine 10Peripheral Blood Stem Cell Transplantation 10Granulocyte Colony-Stimulating Factor 10Mycophenolic Acid 9Filgrastim 9Melphalan 8Antilymphocyte Serum 8Whole-Body Irradiation 7Palliative Care 7Idarubicin 6Blood Specimen Collection 6Methotrexate 5Therapeutics 4Specimen Handling 4Radiotherapy 4Methods 4Early Intervention, Educational 4Daunorubicin 4Cord Blood Stem Cell Transplantation 4thymoglobulin 3Thiotepa 3Tacrolimus 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myeloid, Acute × Interleukin-2 × Clear all
NCT06256627 2024-02-13

The Maintenance Treatment of "ITIVA" in AML Patients

Henan Cancer Hospital

Phase NA Recruiting
130 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00187096 2014-06-19

Natural Killer (NK) Cell Transplantation for AML

St. Jude Children's Research Hospital

Phase NA Completed
49 enrolled 17 charts
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡